Raymond James & Associates’s Dova Pharmaceuticals, Inc. Common Stock DOVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-11,974
| Closed | -$169K | – | 3619 |
|
|
2019
Q2 | $169K | Sell |
11,974
-2,879
| -19% | -$40.6K | ﹤0.01% | 3288 |
|
|
2019
Q1 | $132K | Sell |
14,853
-7,236
| -33% | -$64.3K | ﹤0.01% | 3307 |
|
|
2018
Q4 | $167K | Sell |
22,089
-24,050
| -52% | -$182K | ﹤0.01% | 3184 |
|
|
2018
Q3 | $968K | Sell |
46,139
-2,834
| -6% | -$59.5K | ﹤0.01% | 2278 |
|
|
2018
Q2 | $1.47M | Buy |
+48,973
| New | +$1.47M | ﹤0.01% | 1967 |
|